Paid Ads at Scale: 15x+ Pipeline Value Per Ad Dollar

The Challenge

High-ticket healthcare is one of the hardest paid media environments there is: $20,000-$50,000 treatment decisions, long consideration windows, sales that close offline weeks after the click, and fierce CPC competition. Most agencies in this space optimize for form-fills and call it a day.

The mandate: run a seven-figure annualized ad budget across Meta and Google for a dental implant practice, and make every dollar accountable to actual treatment revenue, not vanity metrics.

---

The Approach

Full-Funnel Accountability

Every campaign plugged into the Salesforce attribution system from day one. Spend was judged on one question: does this produce patients? Not clicks, not leads, consults and collections.

Channel Strategy

• Meta as the volume engine: localized lead-gen campaigns per market, running $15-29 CPL at scale
• Google concentrated on intent: brand search at $6.30 CPL and high-intent implant queries, cutting generic search that ran $59-68 CPL
• Spanish-language campaigns as an underpriced audience: $9-15 CPL for the same procedures
• Creative testing cadence across video testimonials, financing angles, and market-specific offers

Kill Fast, Scale What Works

• TikTok: tested for one month, strong lead volume, near-zero consults, $0 in sold treatment. Killed immediately.
• Generic Google Search: 3-10x the CPL of brand, budget shifted to Meta lead-gen and brand search
• Awareness campaigns cut: cheap CPMs and great reach, but no revenue attached, reallocated to high-intent spend

---

The Numbers

Scaling Spend With Confidence

With revenue attribution in place, monthly ad spend scaled steadily while returns held, growing lead volume from ~1,200/month to 4,000+/month as blended CPL fell 45%.

A Multi-Million Dollar Treatment Pipeline, 15x+ Per Ad Dollar

The spend generated a multi-million dollar treatment pipeline in plans presented, over 15x pipeline value per ad dollar, with the best months reaching 25x.

Top Campaigns vs. Average

Efficiency Compounding

• Blended CPL: down 45% while lead volume more than tripled
• Cost per consult: $231 → $134 as low-intent spend was pruned
• Qualified-lead booking rate: 26.5% → 60.7%

---

Why This Worked

Attribution Bought Courage

Cutting or reallocating six figures of budget is terrifying without data. With collections tied to every campaign, the moves were obvious, and returns went up.

Optimizing for Patients, Not Leads

The cheapest lead is usually the most expensive patient. Feeding real revenue back into the ad platforms trained the algorithms to find people who show up and accept treatment.

Volume Is a Lever, Not a Goal

The account's best months by cost-per-consult came after pruning low-intent spend. We stopped buying cheap leads and started buying patients.

---

Key Takeaways

Judge every dollar by revenue, not lead count. A $25 lead that never books is more expensive than a $50 lead that becomes a $40k case.

Kill losers fast. One month of clean data was enough to end TikTok. Sunk-cost thinking is a budget leak.

Brand search is the cheapest revenue you'll ever buy. $6.30 CPL against a $59-68 generic CPL, defend your brand terms first.

Underpriced audiences exist. Spanish-language campaigns delivered identical procedures at a third of the CPL.

Scale follows visibility. Budgets grow safely only when every dollar reports back to revenue.